Postoperative management after oral cavity resection with a positive margin and a chyle leak
A 55-year-old man underwent a composite resection of a T3N2b floor-of-mouth SCC with mandibulectomy and fibula free flap reconstruction, plus bilateral neck dissection. Final pathology shows a 1 mm close margin at the mandible and a 2 mm margin at the soft tissue, with 2 of 28 nodes positive and no ECE. On postoperative day 4 he develops a high-output chyle leak (600 mL/day) from the left neck drain, and his flap is dusky at the distal edge. He is nil per os with a nasogastric tube.
1. How would you manage the chyle leak and the threatened flap, and what is the priority order?
Read the worked answer
Priority is flap salvage and airway/hemodynamic stability, then leak control.
- Flap assessment: dusky distal edge suggests venous congestion or arterial insufficiency. Urgent bedside assessment and likely surgical exploration by the reconstructive team; do not delay for conservative measures.
- Chyle leak: high output (600 mL/day) requires bowel rest, total parenteral nutrition or a low-fat medium-chain triglyceride diet, and drainage. If output remains high after 5–7 days, consider surgical ligation of the thoracic duct or lymphatic embolization. Octreotide is sometimes used but evidence is limited.
- Drain management: maintain drain patency, monitor electrolytes and volume status, and watch for chylothorax.
- Antibiotics: cover for possible infection, especially with a threatened flap.
The flap takes precedence because flap loss is catastrophic; the chyle leak can be managed concurrently but should not delay re-exploration.
2. What adjuvant therapy would you recommend, and how does the margin status affect the decision?
Read the worked answer
The patient has T3N2b (stage IVA) disease with close margins (1 mm and 2 mm) and no ECE. Close margins (≤5 mm) are a high-risk feature but not the same as a positive margin. The standard is adjuvant radiation to the primary bed and bilateral neck, with consideration of concurrent chemotherapy.
- Positive margin or ECE would mandate chemoradiation (category 1).
- Close margins alone are generally treated with RT alone, but many teams add concurrent cisplatin if there are multiple high-risk features or if the margin is very close (≤1 mm). Here, the 1 mm mandibular margin is concerning; a multidisciplinary discussion should weigh the benefit of chemoradiation against toxicity.
- Dose: 60–66 Gy to the primary bed, with a boost to the close margin region.
The decision should be individualized and documented, and the patient should be counseled about the risks of chemoradiation (mucositis, xerostomia, osteoradionecrosis) versus the risk of local recurrence.